MARK J LEVIN
CIK 1180428 · last filed 2021-11-16
MARK J LEVIN is a corporate insider who has filed 89 SEC Form 4 insider transactions across 14 companies since 2007. The most recent filing shows the insider sold $95.5M of JNCE on Nov 16, 2021. Across all open-market trades the lifetime net is −$1.19B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $115.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$115.57M
14
89
-$1.19B
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. (JNCE) Delisted | 10%+ Owner | 1,432,630 | $1.88 | $2.69M | -$197.76M | 2 | 2021-11-16 |
| FULC | Director | 84,223 | $3.45 | $290.6K | $1.30M | 5 | 2021-11-12 |
| RVMD | 10%+ Owner | 116,334 | $153.87 | $17.90M | -$349.03M | 3 | 2021-06-07 |
| VYGR | Director | 6,424,205 | $3.50 | $22.48M | $0 | 11 | 2021-06-04 |
| NRIX | 10%+ Owner | 3,500,667 | $16.95 | $59.34M | $0 | 1 | 2021-05-10 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | 10%+ Owner | 3,034,083 | $33.99 | $103.13M | $0 | 1 | 2018-08-24 |
| MyoKardia, Inc. (MYOK) Delisted | 10%+ Owner | 280,057 | — | — | $0 | 2 | 2018-03-07 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | 10%+ Owner | 4,475,191 | $68.49 | $306.51M | -$470.21M | 4 | 2017-04-06 |
| CTMX | 10%+ Owner | 5,170,348 | $3.01 | $15.56M | -$172.20M | 2 | 2017-03-27 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 3,570,197 | $129.46 | $462.20M | -$1.23M | 1 | 2017-03-20 |
| Sage Therapeutics, Inc. (SAGE) Delisted | 10%+ Owner | 0 | $8.68 | $0 | $0 | 1 | 2015-01-28 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Director | — | — | — | $0 | 1 | 2014-03-24 |
| Foundation Medicine, Inc. (FMI) Delisted | Director | 6,569,645 | — | — | $0 | 1 | 2013-10-02 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | Director | 400,000 | — | — | -$4.69M | 54 | 2008-05-15 |
Recent Filings
89 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-16 | Jounce Therapeutics, Inc. (JNCE) Delisted | Sell (S) | −11,400,000 | -$95.53M | EDGAR |
| 2021-11-12 | FULC | Other (J) | −1,000,000 | $0 | EDGAR |
| 2021-09-24 | FULC | Other (J) | −1,000,000 | $0 | EDGAR |
| 2021-06-11 | FULC | Grant (A) | — | $0 | EDGAR |
| 2021-06-07 | RVMD | Sell (S) | −3,258,678 | -$98.44M | EDGAR |
| 2021-06-04 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2021-05-27 | RVMD | Sell (S) | −8,197,224 | -$250.59M | EDGAR |
| 2021-05-10 | NRIX | Other (J) | −6,514,704 | $0 | EDGAR |
| 2021-03-03 | Jounce Therapeutics, Inc. (JNCE) Delisted | Sell (S) | −8,700,000 | -$102.22M | EDGAR |
| 2021-02-26 | RVMD | Other (J) | −9,000,000 | $0 | EDGAR |